Currently out of the existing stock ratings of Bob Hopkins, 15 are a HOLD (26.32%), 41 are a BUY (71.93%), 1 are a SELL (1.75%).

Bob Hopkins

Work Performance Price Targets & Ratings Chart

Analyst Bob Hopkins works with a stock forecast success ratio of 70.28% fulfilled within 224.31 days on average.

Bob Hopkins’s has documented 120 price targets and ratings displayed on 17 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on SGHT, Sight Sciences at 12-Sep-2023.

Wall Street Analyst Bob Hopkins

Analyst best performing recommendations are on XENT (INTERSECT ENT).
The best stock recommendation documented was for XENT (INTERSECT ENT) at 4/15/2020. The price target of $10 was fulfilled within 2 days with a profit of $0.79 (8.58%) receiving and performance score of 42.89.

Average potential price target upside

ABT Abbott Laboratories AFIB Acutus Medical  ISRG Intuitive Surgical JNJ Johnson & Johnson PEN Penumbra SWAV Shockwave Medical LUNG Pulmonx Corp MDT Medtronic PLC OM Outset Medical  EW Edwards Lifesciences Corp INSP Inspire Medical Systems BDX Becton Dickinson and Company NARI Inari Medical  PRCT Procept Biorobotics Corp SIBN Si-Bone XENT Intersect ENT SGHT Sight Sciences

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

125

$14.48 (13.10%)

114

9 days ago

4/5 (80%)

$14.89 (13.52%)

388

Buy

141

$30.48 (27.58%)

133

2 months 18 days ago

13/21 (61.9%)

$28.99 (25.88%)

291

Buy

126

$15.48 (14.01%)

130

2 months 19 days ago

7/14 (50%)

$13.55 (12.05%)

292

Buy

127

$16.48 (14.91%)

110

2 months 19 days ago

12/18 (66.67%)

$14.55 (12.94%)

190

Buy

125

$14.48 (13.10%)

125

2 months 20 days ago

6/7 (85.71%)

$14.23 (12.85%)

250

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Bob Hopkins?

On 2014

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?